Myriad Genetics board member Skovronsky resigns
Tweet
Share
E-mail
Get Alerts MYGN Hot Sheet
Join SI Premium – FREE
Daniel M. Skovronsky, M.D., Ph.D., a member of the board of directors of Myriad Genetics (NASDAQ: MYGN), resigned from his position effective June 17, 2026.
According to a company statement, Skovronsky's departure was not the result of any disagreement with the company or any matter relating to its operations, policies, or practices.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing names Ryan Shedd as new SVP and controller
- Alzamend Neuro (ALZN) files for 98.4M share offering by selling stockholders
- Sigma Lithium resumes full operations after signing TAC agreement
Create E-mail Alert Related Categories
Corporate News, Management ChangesRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
